Karyopharm Therapeutics Inc. (KPTI)
NASDAQ·Healthcare·Biotechnology
$1.60
-1.23%
Mkt Cap $38.98M
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (16 analysts)
$13.20
Range $3.00 – $28.00
Implied Upside
+725.0%
Consensus $13.20 vs current $1.60
NASDAQ·Healthcare·Biotechnology
$1.60
-1.23%
Mkt Cap $38.98M
Buy
6
Hold
1
Sell
0
Price Target (16 analysts)
$13.20
Range $3.00 – $28.00
+725.0%
Consensus $13.20 vs current $1.60